Tocilizumab
Tocilizumab
Klass : 3
Visa all info
Skriv ut
Kontakta oss
Saito J, Yakuwa N, Takai C, Nakajima K, Kaneko K, Goto M et al. Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study. Rheumatology (Oxford). 2018
Nakajima K, Watanabe O, Mochizuki M, Nakasone A, Ishizuka N, Murashima A. Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan. Mod Rheumatol. 2016;4:1-5.
Saito J, Yakuwa N, Kaneko K, Takai C, Goto M, Nakajima K et al. Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum. Rheumatology (Oxford). 2019;58(8):1505-1507.
Saito J, Yakuwa N, Kaneko K, Nakajima K, Takai C, Goto M et al. Clinical application of the dried milk spot method for measuring tocilizumab concentrations in the breast milk of patients with rheumatoid arthritis. Int J Rheum Dis. 2019;22(6):1130-1137.
Moriyama M, Wada Y, Minamoto T, Kondo M, Honda M, Murakawa Y. Unexpectedly lower proportion of placental transferred tocilizumab relative to whole immunoglobulin G: a case report. Scand J Rheumatol. 2020;49(2):165-166.
Saito J, Yakuwa N, Kaneko K, Goto M, Kawasaki H, Hamamachi Y et al. Tocilizumab drug levels during pregnancy and lactation: A woman who discontinued tocilizumab therapy until the end of the first trimester and resumed it after birth. Obstet Med. 2021;14(4):260-262.
- Saito J, Yakuwa N, Takai C, Nakajima K, Kaneko K, Goto M et al. Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study. Rheumatology (Oxford). 2018
- Nakajima K, Watanabe O, Mochizuki M, Nakasone A, Ishizuka N, Murashima A. Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan. Mod Rheumatol. 2016;4:1-5.
- Saito J, Yakuwa N, Kaneko K, Takai C, Goto M, Nakajima K et al. Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum. Rheumatology (Oxford). 2019;58(8):1505-1507.
- Saito J, Yakuwa N, Kaneko K, Nakajima K, Takai C, Goto M et al. Clinical application of the dried milk spot method for measuring tocilizumab concentrations in the breast milk of patients with rheumatoid arthritis. Int J Rheum Dis. 2019;22(6):1130-1137.
- Moriyama M, Wada Y, Minamoto T, Kondo M, Honda M, Murakawa Y. Unexpectedly lower proportion of placental transferred tocilizumab relative to whole immunoglobulin G: a case report. Scand J Rheumatol. 2020;49(2):165-166.
- Saito J, Yakuwa N, Kaneko K, Goto M, Kawasaki H, Hamamachi Y et al. Tocilizumab drug levels during pregnancy and lactation: A woman who discontinued tocilizumab therapy until the end of the first trimester and resumed it after birth. Obstet Med. 2021;14(4):260-262.
Innehållet senast uppdaterat 8/14/2024